Institut du Cancer de Montpellier - Val d'Aurelle: Neoplasms trials
The registry lists 13 Neoplasms studies with Institut du Cancer de Montpellier - Val d'Aurelle as lead sponsor. 10 are open to participants now and 0 have results posted.
Phase 2 3No phase 10(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Feasibility Study Incorporating Music Therapy to Optimise the Smoking Cessation Process Coordinated by a Tobacco Addiction Nurse in Smoking Patients Being Treated for CancerRecruitingNCT07198971Not applicable
- Analysis of Circulating Tumor Markers in Blood - ALCINA 5Not yet recruitingNCT07060950Not applicable
- Efficacy of a Mixed Distancial Neuropsychological Rehabilitation Program in Patients With Grade 2 or 3 Diffuse GliomaRecruitingNCT06468176Not applicable
- Dynamics of Motivational Factors for Physical Activity and Nutrition in OncogeriatricsRecruitingNCT06445140Not applicable
- SAHARA-04 : Adaptive Radiotherapy in Hypersensitive Patients and High Locoregional Risk Breast Cancer With ETHOS TechnologyRecruitingNCT06053086Not applicable
- Assessment of Cardiac Coherence Associated With Medical Hypnosis on Preoperative Anxiety in Oncological SurgeryRecruitingNCT05197972Not applicable
- Efficacy of Gembrax Followed by Folfirinox Versus Folfirinox Alone in First Metastatic Line Pancreatic Cancer PatientsRecruitingNCT05065801Phase 2
- Sequential Treatment With GEMBRAX and Then FOLFIRINOX Followed by Stereotactic MRI-guided Radiotherapy in Patients With Locally Advanced Pancreatic CancerRecruitingNCT04570943Phase 2
- Prospective Monocentric Clinical-biological DatabaseRecruitingNCT04136132Not applicable
- Development of a Cinical and Biological Database in Ovarian, Fallopian Tube and Peritoneal CancersRecruitingNCT03976999Not applicable
- Impact of Music Therapy on Pain in Patients Treated for Advanced CancerCompletedNCT05315427Not applicable
- Multicenter Phase 2 Trial: a Tailored Strategy for Locally Advanced Rectal CarcinomaCompletedNCT01333709Phase 2
- Epoetin Beta in Patients Undergoing Chemotherapy for Solid TumorsTerminatedNCT00875004Not applicable